Patient Resources and Records
The Arthritis Clinic of Central Texas has patient resources and records available online for easy accessibility for our patients. On this page you can access your records online. You can also schedule appointments online. You can do this by logging onto Patient Fusion.
We also have resources regarding education in diseases and drugs available on this page. Please click on the links that you would like further education on, and give us a call if you have any other questions or concerns.
Disease Education
Here is a partial list of some of the common diseases and conditions we treat at the Arthritis Clinic of Central Texas:
- Ankylosing spondylitis | Español
- Gout | Español
- Granulomatosis with Polyangiitis (Wegener’s) | Español
- Inflammatory Myopathies | Español
- Systemic Lupus | Español
- Osteoarthritis | Español
- Osteoporosis | Español
- Polymyalgia Rheumatica | Español
- Calcium Pyrophosphate Deposition (CPPD) (formerly called Pseudogout) | Español
- Psoriatic Arthritis | Español
- Raynaud’s Phenomenon | Español
- Reactive Arthritis | Español
- Rheumatoid Arthritis | Español
- Scleroderma | Español
- Sjögren’s Syndrome | Español
- Spinal Stenosis | Español
- Spondyloarthritis | Español
- Tendinitis and Bursitis | Español
- Vasculitis | Español
Drug Education
Your rheumatologist carefully manages your medications to minimize side effects and negative drug interactions. Following are a few of the more commonly prescribed medications:
- Abatacept (Orencia)
- Anakinra (Kineret)
- Anti-TNF (Enbrel, Humira, Remicade, Cimzia, Simponi, Aria)
- Apremilast (Otezla)
- Azathioprine (Imuran)
- Belimumab (Benlysta)
- Bisphosphonate Therapy
- Cyclophosphomide (Cytoxan)
- Cyclosporine (Neoral, Sandimmune, Gengraf)
- Hydroxychloroquine (Plaquenil)
- Leflunomide (Arava)
- Methotrexate (Rheumatrex, Trexall)
- Mycophenolate Mofetil and Mycophenolate Sodium (Cellcept and Myfortic)
- NSAIDs
- Rituximab (Rituxan and MabThera)
- Secukinumab (Cosentyx)
- Sulfasalazine (Azulfidine)
- Teriparatide (Forteo)
- Tocilizumab (Actemra)
- Tofacitinib (Citrate, Xeljanz)